Literature DB >> 25797859

Assessment of the introduction of an adolescent transition urology clinic using a validated questionnaire.

Mohamed Sameh Shalaby1, Anthony Gibson2, Paraskeve Granitsiotis3, Graeme Conn3, Salvatore Cascio2.   

Abstract

BACKGROUND: Adolescents with complex urological conditions are at risk of bladder dysfunction, metabolic disturbances, neoplastic changes and deterioration in renal function. Hence they require appropriate transition to the adult service to ensure lifelong urological care is adequately provided.
OBJECTIVE: Barriers and difficulties to the transition process have been identified in the literature. To overcome these difficulties an Adolescent Transition Urology Clinic (ATUC) was established in 2009 where the patients are seen by a paediatric and an adult urologist, a urology nurse and if needed an adolescent gynaecologist. Our aim was to assess the ATUC and present the patient's perspective to this new service using a validated questionnaire.
MATERIALS AND METHODS: Data of all patients seen at the ATUC over the study period were prospectively recorded. Patients who completed the transition were contacted and asked to complete two online urological transition questionnaires: 1) The Care Transition Measure 15 (CTM-15) which is a validated questionnaire to assess the quality of care during transition from the patients' perspective. 2) The Transition Care Experience (TCE) which was created for the purpose of this study.
RESULTS: Thirty patients attended the ATUC over 4.5 years, with 26 (87%) completing the transition to the adult urological care. Of the 26 patients there were 14 (54%) males with a mean age of 18 years. The most common underlying urological condition was neurogenic bladder (85%). Nineteen (73%) patients completed the questionnaires. Only 1 (5%) patient thought that attending the ATUC was not beneficial, 17 (89%) would recommend the ATUC to other adolescents and 9 (47%) patients considered 18 as the appropriate transition age. Overall, 74% thought that written information would have been useful and 21% considered the adult hospital as an inappropriate environment for young adults. After attending the ATUC, 2 (11%) patients thought their preferences were not met and 3 (16%) patients were not confident that they can take care of their health. DISCUSSION: Transition of patients with complex urological conditions should aim to facilitate transferring the care from the parent to the patient and preparing the adolescent to adult life by addressing their sexual and reproductive functions. Inadequate transition can have serious health consequences. On-going communication between the paediatric and the adult urologist facilitates the transition process even after the transfer of care has occurred. The CTM-15 has been considered as "the only available measure of quality of care during transition from the patients' perspective". Our study suggests that the large majority of adolescent attending the clinic are confident in looking after their complex urological condition. In addition one patient in 5 found the adult hospital environment an inappropriate place for adolescents and they would have preferred longer follow up in a children's hospital. The value of written information after clinic consultation seems to be a useful adjunct that might facilitate the complex transition process.
CONCLUSION: This is the first report evaluating the transition of adolescents with complex urological conditions using a validated transition questionnaire. The combined paediatric/adult urology clinic is beneficial in addressing the patients' needs and allowing smooth transition of these complex patients to the adult service.
Copyright © 2015 Journal of Pediatric Urology Company. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adolescent; CTM-15; Neurogenic bladder; Questionnaire; Spina bifida; Transition

Mesh:

Year:  2015        PMID: 25797859     DOI: 10.1016/j.jpurol.2014.11.024

Source DB:  PubMed          Journal:  J Pediatr Urol        ISSN: 1477-5131            Impact factor:   1.830


  7 in total

1.  Demographics and baseline care among newly transitioning adult congenital urology patients.

Authors:  Natalia V Leva; Hillary L Copp; Kathryn Quanstrom; Lindsay A Hampson
Journal:  J Pediatr Urol       Date:  2020-06-01       Impact factor: 1.830

Review 2.  A proposed solution to a urological tightrope walk: The challenge of transition of spina bifida patients from pediatric to adult care in Ontario.

Authors:  Martin A Koyle; Nicole Golda; Christopher Hillis; Betty Oldershaw; Margaret DeMelo; Jennifer Uyeno
Journal:  Can Urol Assoc J       Date:  2016 Sep-Oct       Impact factor: 1.862

Review 3.  Spina bifida.

Authors:  Alvaro A Saavedra; Dawn Maclellan; Gary J Gray
Journal:  Can Urol Assoc J       Date:  2018-04       Impact factor: 1.862

4.  Facilitating transition of young people with long-term health conditions from children's to adults' healthcare services - implications of a 5-year research programme.

Authors:  Allan Colver; Tim Rapley; Jeremy R Parr; Helen McConachie; Gail Dovey-Pearce; Ann Le Couteur; Janet E McDonagh; Caroline Bennett; Gregory Maniatopoulos; Mark S Pearce; Debbie Reape; Nichola Chater; Helena Gleeson; Luke Vale
Journal:  Clin Med (Lond)       Date:  2020-01       Impact factor: 2.659

Review 5.  The Management of the Pediatric Neurogenic Bladder.

Authors:  Renea M Sturm; Earl Y Cheng
Journal:  Curr Bladder Dysfunct Rep       Date:  2016-07-02

6.  Evaluating outpatient transition clinics: a mixed-methods study protocol.

Authors:  Jane N T Sattoe; Mariëlle A C Peeters; Sander R Hilberink; Erwin Ista; AnneLoes van Staa
Journal:  BMJ Open       Date:  2016-08-26       Impact factor: 2.692

7.  A longitudinal, observational study of the features of transitional healthcare associated with better outcomes for young people with long-term conditions.

Authors:  A Colver; H McConachie; A Le Couteur; G Dovey-Pearce; K D Mann; J E McDonagh; M S Pearce; L Vale; H Merrick; J R Parr
Journal:  BMC Med       Date:  2018-07-23       Impact factor: 8.775

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.